Enplas (6961) Q3 2025 earnings summary

Executive summary

• Sales increased by 3.0% year-over-year to 28,805 million yen for the first nine months of FY2025.3, with operating income up 14.9% and profit attributable to owners of parent up 25.8%.

• Growth was driven by steady performance in Life Science and Energy Saving Solution segments, offsetting weakness in Semiconductor and Digital Communication.

• Comprehensive income for the period reached 4,183 million yen, up from 3,447 million yen in the prior year.

Financial highlights

• Operating margin improved by 1.5 points year-over-year to 14.2%.

• Earnings per share rose by 66.43 yen to 325.21 yen.

• Gross profit for the nine months was 13,300 million yen, up from 12,875 million year-over-year.

• SG&A expenses decreased by 104 million yen, mainly due to lower labor and travel costs, despite a rise in R&D expenses.

• Non-operating income benefited from higher interest income but was offset by FX losses.

Outlook and guidance

• Full-year sales forecast revised down to 38,000 million yen from 41,500 million yen; operating income forecast at 5,100 million yen.

• Planned FX rate for the remainder of the year is 150 yen/USD.

• No revision to forecasts for Life Science and Energy Saving Solution segments.

• Full-year earnings per share forecast is 407.46 yen.

• Annual dividend forecast is 60.00 yen per share.